Commercial coverage

Does Blue Cross Blue Shield of Texas cover Mounjaro?

Mounjaro (tirzepatide) for type 2 diabetes — the Blue Cross Blue Shield of Texas prior-authorization rule, source-cited.

Covered with prior authorizationPolicy as of 2026 (diabetes eff. 05-11-2026; weight management eff. 05-18-2026) · verified · Reviewed by the D3rx Clinical Billing Team

Blue Cross Blue Shield of Texas Mounjaro PA criteria

Covers Ozempic, Rybelsus, Mounjaro, Trulicity, Bydureon BCise, Byetta/Exenatide, Victoza/liraglutide (PA with Quantity Limit via Prime).

Initial requires ALL of: diagnosis of T2DM; confirmed by ONE lab - A1C >=6.5%, FPG >=126, 2-hr OGTT PG >=200, or random PG >=200 with hyperglycemia symptoms; step therapy (preferred agents Bydureon BCise/Mounjaro/Ozempic/Rybelsus/Trulicity approvable directly; non-preferred Byetta/Exenatide/Victoza-liraglutide require TWO of: tried/failed/intolerant/contraindicated to semaglutide, dulaglutide, and/or tirzepatide); age within FDA labeling; not combined with a DPP-4 agent or another GLP-1; no FDA contraindications.

No prior metformin trial required.

Approval 12 months (BCBSOK 36 months; BCBSIL 12).

Quantity limit one GLP-1 agent and one strength per 28 days.

Source: HCSC/Prime Commercial GLP-1 Agonists PAQL Program Summary (eff. 05-11-2026) & Weight Management PAQL Program Summary (eff. 05-18-2026). View cited GLP-1 policy reference →

Note: tirzepatide is also sold as Zepbound for weight loss / obesity, which Blue Cross Blue Shield of Texas evaluates under a separate weight loss / obesity policy (not this one) — see does Blue Cross Blue Shield of Texas cover Zepbound?. Coverage follows the brand's FDA indication, not the molecule.

Frequently asked

Does Blue Cross Blue Shield of Texas cover Mounjaro for type 2 diabetes?
Covered with prior authorization. Covers Ozempic, Rybelsus, Mounjaro, Trulicity, Bydureon BCise, Byetta/Exenatide, Victoza/liraglutide (PA with Quantity Limit via Prime). See the full source-cited criteria above. Per HCSC/Prime Commercial GLP-1 Agonists PAQL Program Summary (eff. 05-11-2026) & Weight Management PAQL Program Summary (eff. 05-18-2026), as of 2026 (diabetes eff. 05-11-2026; weight management eff. 05-18-2026) — confirm the member's current plan policy.

d3rx does not hold plan-specific pharmacy formularies or PBM prior-auth grids, so it cannot confirm a particular plan's GLP-1 coverage, tier, or PA criteria. The guidance below is the general, source-cited rule; confirm the specific plan's pharmacy formulary / PA policy for a binding answer.

Check Mounjaro for another payer — or draft the PA

Run Mounjaro + any payer in the GLP-1 PA lookup, or have Ask D3 draft a Blue Cross Blue Shield of Texas-ready prior-authorization request with the right criteria and codes — free, no signup.

Does another payer cover Mounjaro?